/Pemphigoid Group/BULLOUS PEMPHIGOID 4-u1.0-B978-1-4160-2999-1..50036-9--cesec2 4-u1.0-B978-1-4160-2999-1..50036-9..DOCPDF VESICULOBULLOUS DISEASES 4-u1.0-B978-1-4160-2999-1..50036-9 Chapter 31 4-u1.0-B978-1-4160-2999-1..50036-9 4-u1.0-B978-1-4160-2999-1..50036-9 SECTION FIVE hubsection BULLOUS PEMPHIGOID chapter 4-u1.0-B978-1-4160-2999-1..50036-9--cesec23 BULLOUS PEMPHIGOID Chapter 31 VOLUME 1 4-u1.0-B978-1-4160-2999-1..50036-9--cesec2 VOLUME 1 hubvolume 4 4-u1.0-B978-1-4160-2999-1..50036-9 Pemphigoid Group 4-u1.0-B978-1-4160-2999-1..X5001-2--volume1 text/html; charset=ISO-8859-1 Pemphigoid Group VESICULOBULLOUS DISEASES 4-u1.0-B978-1-4160-2999-1..X5001-2--section5 bookContent 4-u1.0-B978-1-4160-2999-1..X5001-2--volume1 4-u1.0-B978-1-4160-2999-1..X5001-2--section5 4-u1.0-B978-1-4160-2999-1..X5001-2--section5 4-u1.0-B978-1-4160-2999-1..50035-7--cebib1 6 SECTION FIVE section 4-u1.0-B978-1-4160-2999-1..50036-9--cesec2 Pemphigoid Group 4-u1.0-B978-1-4160-2999-1..50036-9 Chapter 31 Dermatology 978-1-4160-2999-1 Bolognia 2nd
Chapter 31 – Pemphigoid GroupLuca Borradori,
Philippe Bernard
BULLOUS PEMPHIGOID
| Key features |
| | ▪
| Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease, and it predominantly affects the elderly
| | | ▪
| It is usually a chronic disease, with spontaneous exacerbations and remissions, which may be accompanied by significant morbidity
| | | ▪
| BP is associated with tissue-bound and circulating autoantibodies directed against the BP antigen 180 (BP180, BPAG2 or type XVII collagen) and the BP antigen 230 (BP230 or BPAG1), components of junctional adhesion complexes called hemidesmosomes that promote dermo-epidermal cohesion
| | | ▪
| The spectrum of clinical presentations is extremely broad. Characteristically, BP is an intensely pruritic eruption with widespread blister formation. In early stages, or in atypical variants of the disease, only excoriated, eczematous or urticarial lesions (either localized or generalized) are present
| | | ▪
| Diagnosis relies on immunopathologic examinations, …
|
|